Individuals with T2DM taking tirzepatide, a dual GIP and GLP- 1 receptor agonist, experienced better weight loss and blood sugar control than patients taking GLP- 1 receptor agonism
You might be familiar with IV drips in hospital settings, but recently, this therapy option crossed over into the mainstream
-, overall negative effects
Unlike many peptides that degrade quickly in the digestive system, BPC-157 demonstrates remarkable stability and bioavailability, making it effective through multiple administration routes including oral, subcutaneous, and intramuscular delivery
Functional medicine treats the whole person, identifying the root conditions gut dysbiosis, immune dysregulation, hormonal disruption that allowed Candida to overgrow, rather than only suppressing the yeast itself